Literature DB >> 307491

Factors influencing surfactant composition in the newborn infant.

M Obladen.   

Abstract

In order to evaluate the surfactant maturation of the neonate, tracheal aspirates were analyzed in 84 newborn infants with 12h of birth. Using 2-dimensional thin-layer chromatography, 9 different phospholipids were identified. Dynamic surface tension measurements were performed with a modified Wilhelmy balance. Five different groups of infants with typical phospholipid patterns were characterized: i.e., 1. Normal term newborn. 2. RDS in the preterm infant. 3. Acceleration of lung maturity in preterm infants without RDS. 4. Retardation in term infants with RDS. 5. Therapeutic induction of pulmonary maturity in preterm infants following maternal glucocorticoid administration. Mature lung effluent contains high concentrations of phosphatidylcholine (PC) and phsophatidylglycerol (PG). In infants with RDS, PC is low and PG absent. Accelerated lung maturity was observed after chronic prenatal stress, such as prolonged rupture of the membranes, chronic vaginal bleeding, and maternal hepatitis or drug addiction. Retardation of pulmonary maturity was seen in infants with alpha-1-AT-deficiency, maternal diabetes and maternal hypothyroidism. Administration of methylprednisolone to the mother 24 h to 72h before birth induced both the synthesis of PC and PG in the preterm infants, resulting in an almost full-term phospholipid pattern as early as 31 weeks of gestation. The significance of these factors on the pathogenesis of RDS is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307491     DOI: 10.1007/bf00444298

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  59 in total

Review 1.  Respiratory distress syndrome, surfactant biochemistry, and acceleration of fetal lung maturity: a review.

Authors:  B J Brown; H A Gabert; M A Stenchever
Journal:  Obstet Gynecol Surv       Date:  1975-02       Impact factor: 2.347

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  [RDS--no longer an idiopathic respiratory disease].

Authors:  G Arvidson; L Ekelund; B Astedt
Journal:  Lakartidningen       Date:  1976-09-15

4.  A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.

Authors:  G C Liggins; R N Howie
Journal:  Pediatrics       Date:  1972-10       Impact factor: 7.124

5.  Methods for determining the fraction of pulmonary surfactant lipid removed from the lung of beagle dogs by lavage.

Authors:  F Henderson; J J Waide; R C Pfleger
Journal:  Arch Int Physiol Biochim       Date:  1974

6.  Phospholipid composition of human amniotic fluid during gestation and at term.

Authors:  G Arvidson; H Ekelund; B Astedt
Journal:  Acta Obstet Gynecol Scand       Date:  1972       Impact factor: 3.636

7.  The effect of hyperventilation on the size and shape of alveoli.

Authors:  J B Forrest
Journal:  Br J Anaesth       Date:  1970-10       Impact factor: 9.166

8.  Amniotic-fluid cortisol and human fetal lung maturation.

Authors:  S M Sharp-Cageorge; B M Blicher; E R Gordon; B E Murphy
Journal:  N Engl J Med       Date:  1977-01-13       Impact factor: 91.245

9.  Restoration of lung pressure-volume characteristics with surfactant: comparison of nebulization versus instillation and natural versus synthetic surfactant.

Authors:  M Ikegami; T Hesterberg; M Nozaki; F H Adams
Journal:  Pediatr Res       Date:  1977-03       Impact factor: 3.756

10.  Expansion pattern of terminal air-spaces in the premature rabbit lung after tracheal deposition of surfactant.

Authors:  G Grossmann
Journal:  Pflugers Arch       Date:  1977-01-17       Impact factor: 3.657

View more
  9 in total

1.  Lecithin/sphingomyelin ratio from tracheal aspirates and compliance of the respiratory system in infants with bronchopulmonary dysplasia.

Authors:  E Kattner; R Maier; E Waiss; P Stevens
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Respiratory distress syndrome in very low birth weigh infants with occasionally normal surfactant phospholipids.

Authors:  K Kankaanpää; M Hallman
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

3.  Amniotic fluid fluorescence polarisation values for assessing fetal lung maturation.

Authors:  M Legge; H C Potter
Journal:  J Clin Pathol       Date:  1981-10       Impact factor: 3.411

4.  Surfactant substitution.

Authors:  M Obladen; F Brendlein; B Krempien
Journal:  Eur J Pediatr       Date:  1979-08       Impact factor: 3.183

5.  Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities.

Authors:  M Obladen; W Kampmann; I Zimmermann; B Lachmann
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

6.  Evidence of surfactant deficiency in persistence of the fetal circulation.

Authors:  M Hallman; K Kankaanpää
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

7.  Sustained Aeration of Infant Lungs (SAIL) trial: study protocol for a randomized controlled trial.

Authors:  Elizabeth E Foglia; Louise S Owen; Marta Thio; Sarah J Ratcliffe; Gianluca Lista; Arjan Te Pas; Helmut Hummler; Vinay Nadkarni; Anne Ades; Michael Posencheg; Martin Keszler; Peter Davis; Haresh Kirpalani
Journal:  Trials       Date:  2015-03-15       Impact factor: 2.279

8.  Delivery room interventions to prevent bronchopulmonary dysplasia in preterm infants: a protocol for a systematic review and network meta-analysis.

Authors:  Souvik Mitra; Timothy Disher; Gerhard Pichler; Brandon D'Souza; Helen Mccord; Varsha Chayapathi; Karlee Jones; Georg Schmölzer
Journal:  BMJ Open       Date:  2019-08-18       Impact factor: 2.692

Review 9.  Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants.

Authors:  E E Foglia; E A Jensen; H Kirpalani
Journal:  J Perinatol       Date:  2017-06-01       Impact factor: 2.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.